Publications

Time-Dependent Protective and Pro-Resolving Effects of FPR2 Agonists on Lipopolysaccharide-Exposed Microglia Cells Involve Inhibition of NF-κB and MAPKs Pathways. Kinga Tylek, Ewa Trojan, Monika Leśkiewicz, Magdalena Regulska, Natalia Bryniarska, Katarzyna Curzytek, Enza Lacivita, Marcello Leopoldo, Agnieszka Basta-Kaim
Cells, 2373 10.3390/cells10092373
PMID:34572022
Thursday, 9 September 2021
The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1-42)-Induced Neuroinflammation in Mouse Models of Alzheimer's Disease. Ewa Trojan, Kinga Tylek, Nicole Schröder, Iris Kahl, Lars-Ove Brandenburg, Margherita Mastromarino, Marcello Leopoldo, Agnieszka Basta-Kaim, Enza Lacivita
Molecular neurobiology, 10.1007/s12035-021-02543-2
PMID:34468933
Wednesday, 1 September 2021
The emerging role of mechanical and topographical factors in the development and treatment of nervous system disorders: dark and light sides of the force. Natalia Bryniarska-Kubiak, Andrzej Kubiak, Małgorzata Lekka, Agnieszka Basta-Kaim
Pharmacological reports : PR, 10.1007/s43440-021-00315-2
PMID:34390472
Saturday, 14 August 2021
The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Exhibits Anti-Inflammatory Activity in LPS-Stimulated Organotypic Hippocampal Cultures. Ewa Trojan, Kinga Tylek, Monika Leśkiewicz, Władysław Lasoń, Lars-Ove Brandenburg, Marcello Leopoldo, Enza Lacivita, Agnieszka Basta-Kaim
Cells, 1524 10.3390/cells10061524
PMID:34204273
Thursday, 17 June 2021
Formyl peptide receptor 2, as an important target for ligands triggering the inflammatory response regulation: a link to brain pathology. Kinga Tylek, Ewa Trojan, Magdalena Regulska, Enza Lacivita, Marcello Leopoldo, Agnieszka Basta-Kaim
Pharmacological reports : PR, 10.1007/s43440-021-00271-x
PMID:34105114
Tuesday, 8 June 2021
Venlafaxine and L-Thyroxine Treatment Combination: Impact on Metabolic and Synaptic Plasticity Changes in an Animal Model of Coexisting Depression and Hypothyroidism. Katarzyna Głombik, Jan Detka, Bogusława Budziszewska
Cells, 1394 10.3390/cells10061394
PMID:34198731
Saturday, 5 June 2021
Targeting the CCL2-CCR2 axis in depressive disorders. Katarzyna Curzytek, Monika Leśkiewicz
Pharmacological reports : PR, 10.1007/s43440-021-00280-w
PMID:34031863
Monday, 24 May 2021
Shedding light on the role of CX3CR1 in the pathogenesis of schizophrenia. Katarzyna Chamera, Magdalena Szuster-Głuszczak, Agnieszka Basta-Kaim
Pharmacological reports : PR, 10.1007/s43440-021-00269-5
PMID:34021899
Saturday, 22 May 2021
Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression. Jan Detka, Katarzyna Głombik
Pharmacological reports : PR, 10.1007/s43440-021-00274-8
PMID:34003475
Tuesday, 18 May 2021
Immune-Regulatory and Molecular Effects of Antidepressants on the Inflamed Human Keratinocyte HaCaT Cell Line. Curzytek K, Maes M, Kubera M
Neurotoxicity research, 10.1007/s12640-021-00367-5
PMID:33945102
Tuesday, 4 May 2021